BRWA
NH

B. Riley Wealth Advisors’s NantHealth, Inc NH Stock Holding History

B. Riley Wealth Advisors’s Portfolio NH Stock Details NH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,629
Closed -$18K – 1624
2022
Q3 		$18K Buy
+4,629
New +$32.9K ﹤0.01% 1425

Other funds holding NH

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

B. Riley Wealth Advisors's NH Position: Q4 2022 in Review

B. Riley Wealth Advisors sold out of NantHealth, Inc (NH) in Q4 2022, closing a stake of 4,629 shares — an estimated $18K sold.

B. Riley Wealth Advisors first reported a position in NH in Q3 2022 and held it in 1 quarter. The position peaked at $18K in Q3 2022. 18 funds tracked by Wall St. Rank hold NH as of Q4 2022.

  • B. Riley Wealth Advisors reported no remaining NantHealth, Inc position as of Q4 2022 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 4,629 NantHealth, Inc shares in Q4 2022, an estimated $18K.
  • B. Riley Wealth Advisors first reported a position in NantHealth, Inc in Q3 2022 and held it in 1 quarter.
  • B. Riley Wealth Advisors's NantHealth, Inc position peaked at $18K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held NantHealth, Inc as of Q4 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2022, filed 21 Feb 2023.